Françoise Valensi

5.2k total citations · 1 hit paper
86 papers, 3.5k citations indexed

About

Françoise Valensi is a scholar working on Pathology and Forensic Medicine, Genetics and Immunology. According to data from OpenAlex, Françoise Valensi has authored 86 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 29 papers in Genetics and 29 papers in Immunology. Recurrent topics in Françoise Valensi's work include Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Acute Myeloid Leukemia Research (20 papers). Françoise Valensi is often cited by papers focused on Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Acute Myeloid Leukemia Research (20 papers). Françoise Valensi collaborates with scholars based in France, Switzerland and United States. Françoise Valensi's co-authors include Bruno Varet, Olivier Hermine, Georges Flandrin, Xavier Troussard, François Lefrère, Marie‐Thérèse Daniel, P. Cacoub, Xavier Mariette, Elizabeth Macintyre and Roland Berger and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Françoise Valensi

83 papers receiving 3.3k citations

Hit Papers

Regression of Splenic Lymphoma with Villous Lymphocytes a... 2002 2026 2010 2018 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection
    2002 554 citations Olivier Hermine, François Lefrère et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Françoise Valensi France 30 1.2k 1.1k 936 876 813 86 3.5k
Jean‐Claude Brouet France 33 1.0k 0.9× 1.2k 1.1× 1.3k 1.4× 887 1.0× 1.3k 1.6× 81 5.3k
Roberto Marasca Italy 35 1.2k 1.0× 1.4k 1.2× 821 0.9× 1.8k 2.0× 771 0.9× 128 4.1k
Naokuni Uike Japan 37 1.8k 1.5× 852 0.8× 772 0.8× 1.8k 2.0× 743 0.9× 151 5.1k
Benjamín Koziner United States 34 1.7k 1.4× 1.3k 1.1× 943 1.0× 1.3k 1.4× 534 0.7× 120 4.0k
Tomohiro Kinoshita Japan 35 2.3k 1.9× 937 0.8× 530 0.6× 2.0k 2.3× 1.1k 1.3× 158 4.4k
C. De Wolf‐Peeters Belgium 28 1.0k 0.9× 490 0.4× 533 0.6× 821 0.9× 373 0.5× 78 2.8k
J C Brouet France 28 553 0.5× 725 0.7× 992 1.1× 626 0.7× 684 0.8× 70 2.9k
Jun Taguchi Japan 29 485 0.4× 354 0.3× 691 0.7× 728 0.8× 347 0.4× 194 2.9k
JG Gribben United States 28 1.1k 0.9× 825 0.7× 887 0.9× 1.3k 1.5× 662 0.8× 57 4.3k
S Poppema Netherlands 36 1.8k 1.5× 752 0.7× 192 0.2× 1.7k 1.9× 1.0k 1.3× 93 4.6k

Countries citing papers authored by Françoise Valensi

Since Specialization
Citations

This map shows the geographic impact of Françoise Valensi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Valensi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Valensi more than expected).

Fields of papers citing papers by Françoise Valensi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Valensi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Valensi. The network helps show where Françoise Valensi may publish in the future.

Co-authorship network of co-authors of Françoise Valensi

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Valensi. A scholar is included among the top collaborators of Françoise Valensi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Valensi. Françoise Valensi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Letestu, Rémi, Christophe Marzac, Ramdane Belhocine, et al.. (2006). Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring. Leukemia & lymphoma. 48(1). 89–96. 27 indexed citations
2.
Ugo, Valérie, Nathalie Leporrier, Véronique Salaün, et al.. (2006). Deciphering leukemic B-cell chronic lymphoproliferative disorders. Leukemia & lymphoma. 47(10). 2088–2095. 16 indexed citations
3.
Garçon, Loïc, Éric Delabesse, Françoise Valensi, et al.. (2005). DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification. Leukemia. 19(8). 1338–1344. 29 indexed citations
4.
Asnafi, Vahid, Kheïra Beldjord, Richard Garand, et al.. (2004). IgH DJ rearrangements within T-ALL correlate with cCD79a expression, an immature/TCRγδ phenotype and absence of IL7Rα/CD127 expression. Leukemia. 18(12). 1997–2001. 8 indexed citations
5.
Valensi, Françoise. (2004). Morphologie des cellules sanguines normales. 2(1). 1–13. 2 indexed citations
6.
Damaj, Gandhi, D. Canioni, Marie Thérèse Rubio, et al.. (2002). Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy. European Journal Of Haematology. 68(4). 233–235. 2 indexed citations
7.
Hermine, Olivier, François Lefrère, Jean–Pierre Bronowicki, et al.. (2002). Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection. New England Journal of Medicine. 347(2). 89–94. 554 indexed citations breakdown →
8.
Zermati, Yaël, Carmen Garrido, Sophie Amsellem, et al.. (2001). Caspase Activation Is Required for Terminal Erythroid Differentiation. The Journal of Experimental Medicine. 193(2). 247–254. 325 indexed citations
9.
Delabesse, Éric, Kheïra Beldjord, Frédéric Davi, et al.. (2000). The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype. Blood. 96(6). 2254–2261. 2 indexed citations
10.
Mégarbane, Bruno, Christine Bodemer, Françoise Valensi, et al.. (2000). Association of acute neutrophilic dermatosis and myelodysplastic syndrome with (6; 9) chromosome translocation: a case report and review of the literature. British Journal of Dermatology. 143(6). 1322–1324. 8 indexed citations
11.
Zermati, Yaël, Serge Fichelson, Françoise Valensi, et al.. (2000). Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Experimental Hematology. 28(8). 885–894. 134 indexed citations
12.
Delabesse, Éric, Muriel Bernard, Valérie Meyer, et al.. (1998). TAL1 expression does not occur in the majority of T‐ALL blasts. British Journal of Haematology. 102(2). 449–457. 15 indexed citations
13.
Soulier, Jean, A Madani, Hélène Dastot, et al.. (1997). Alternative origin of p13MTCP1-encoding transcripts in mature T-cell proliferations with t(X;14) translocations. Oncogene. 15(11). 1329–1335. 8 indexed citations
14.
Delabesse, Éric, Muriel Bernard, Judith Landman‐Parker, et al.. (1997). Simultaneous SIL‐TAL1 RT‐PCR detection of all tald deletions and identification of novel tald variants. British Journal of Haematology. 99(4). 901–907. 31 indexed citations
15.
Brizard, André, et al.. (1996). Mastocytoses systémiques associées à un syndrome myélodysplasique. Hématologie. 2(6). 1 indexed citations
16.
Hennequin, Christophe, et al.. (1996). Les difficultés diagnostiques du paludisme d'aéroport. Hématologie. 2(4). 2 indexed citations
17.
Gérard, Y, R Pradinaud, Michel Joubert, et al.. (1995). Clustering and clinical diversity of adult T‐cell leukemia/lymphoma associated with HTLV‐I in a remote black population of French Guiana. International Journal of Cancer. 60(6). 773–776. 27 indexed citations
18.
Poirel, Hélène A., I Radford-Weiss, Katrina Rack, et al.. (1995). Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias. Blood. 85(5). 1313–1322. 82 indexed citations
19.
Cordell, J L, Jacques J. M. van Dongen, Kingsley Micklem, et al.. (1991). The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. The Journal of Immunology. 147(8). 2474–2482. 113 indexed citations
20.
Laval-Jeantet, M, et al.. (1985). [Value and limitations of puncture guided by x-ray computed tomography in hematology].. PubMed. 66(10). 575–80. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Claude Brouet Breakdown of academic impact, for papers by Roberto Marasca Breakdown of academic impact, for papers by Naokuni Uike Breakdown of academic impact, for papers by Benjamín Koziner Breakdown of academic impact, for papers by Tomohiro Kinoshita Breakdown of academic impact, for papers by C. De Wolf‐Peeters Breakdown of academic impact, for papers by J C Brouet Breakdown of academic impact, for papers by Jun Taguchi Breakdown of academic impact, for papers by JG Gribben Breakdown of academic impact, for papers by S Poppema
Rankless by CCL
2026